Scheriproct Ointment 30gm in Kenya

SCHERIPROCT OINTMENT comes in a 30gm tube. It contains two active ingredients: Prednisolone Caproate (a corticosteroid) and Cinchocaine Hydrochloride (a local anesthetic). This ointment specifically provides short-term relief (typically 5 to 7 days) from the uncomfortable symptoms of anal itching and piles (haemorrhoids). While Scheriproct suppositories often suit internal piles better, the ointment offers versatility. You can apply it to the anal area for external piles or insert it into the back passage using the provided applicator for internal piles. Apply it in a thin layer twice daily. For rapid initial improvement, you may apply Scheriproct ointment three to four times on the first day. The nozzle facilitates intra-rectal application.

Important Note: Avoid long-term usage of this drug. Prolonged use may cause thinning of the anal inner lining. Use for a maximum of 7 days, and if symptoms persist, seek further guidance from a doctor. This medication is generally available without a prescription in Kenya.

Unpacking the Formulation: Key Components and Their Mechanism

Scheriproct Ointment’s effectiveness stems from its dual-action formula. It combines an anti-inflammatory corticosteroid with a local anesthetic for comprehensive relief.

• Prednisolone Caproate:
  • Class: Corticosteroid (medium-potency).
  • Mechanism of Action: Prednisolone, a potent anti-inflammatory, reduces the body’s inflammatory response in affected tissues. It decreases swelling, redness, and heat, alleviating the inflammation and swelling that cause pain and discomfort in haemorrhoids and other anorectal conditions.
• Cinchocaine Hydrochloride:
  • Class: Local Anesthetic.
  • Mechanism of Action: Cinchocaine reversibly blocks nerve impulses locally. It specifically inhibits the initiation and conduction of pain signals along nerve fibers. This produces a numbing effect, offering rapid relief from pain, itching, burning, and soreness associated with irritated anorectal tissues.

Together, these ingredients provide comprehensive relief: the corticosteroid addresses inflammation, while the local anesthetic offers immediate symptomatic comfort.

Addressing Health Concerns and User Needs

Scheriproct Ointment directly addresses the prevalent and often distressing symptoms of anorectal conditions. This significantly improves patient comfort.

• Rapid Pain and Itch Relief: Cinchocaine quickly numbs the area, providing fast relief from pain, burning, and intense itching (pruritus).

• Reduced Inflammation: Prednisolone effectively reduces swelling and inflammation associated with haemorrhoids and other irritated tissues.

• Dual-Action Relief: The combination offers more complete symptom control than single-ingredient products.
• Versatile Application: Suitable for both external and internal haemorrhoids due to its ointment form and applicator.
• Improved Comfort: Alleviates overall discomfort, supporting a better quality of life during flare-ups.

Identifying Indications for Use

SCHERIPROCT OINTMENT (PREDNISOLONE + CINCHOCAINE) is indicated for short-term symptomatic relief from conditions affecting the anorectal area:

• Haemorrhoids (Piles): Effective for both external and internal haemorrhoids, particularly when inflamed, painful, or itchy.
• Anal Itching (Pruritus ani): Provides relief from persistent itching around the anus.
• Milder forms of Anal Fissures: Addresses the pain and discomfort of small tears in the anal lining.
• Proctitis: Helps reduce inflammation of the rectal lining.
• Postoperative Pain Relief: Can manage pain and discomfort following anal or rectal surgery.

Primary Uses

The primary uses of SCHERIPROCT OINTMENT include:

• Soothing inflamed haemorrhoids and reducing associated pain and itching.
• Alleviating persistent anal itching caused by various irritations.
• Providing comfort for mild anal fissures by reducing pain.
• Managing post-surgical discomfort in the anorectal region.

Understanding Potential Side Effects and Critical Precautions

While Scheriproct Ointment offers effective relief, users must understand its potential side effects and adhere to necessary precautions, especially regarding duration of use.

Common Side Effects (Generally mild and at the application site)

• Temporary burning or stinging sensation upon application (usually mild and subsides quickly).
• Allergic skin reactions (rare, but possible, including redness or rash).
• Skin thinning (atrophy) with prolonged or excessive use.
• Skin discoloration (rare).

Less Common but More Serious Side Effects (Requiring Medical Attention)

• Systemic Absorption: Although applied topically, prolonged, excessive, or widespread use of corticosteroids can lead to systemic absorption. This potentially causes side effects similar to oral steroids, such as adrenal suppression (especially in children) or Cushing’s syndrome-like symptoms. This is rare with short-term, recommended use.
• Worsening of Infections: Corticosteroids can mask or worsen existing infections (viral, bacterial, fungal). If the treated area shows signs of infection, a doctor should treat it concurrently with an appropriate antimicrobial.
• Severe Allergic Reactions: Rare but serious reactions, including swelling of the face, lips, tongue, difficulty breathing, or a widespread rash, require immediate medical attention.

Critical Safety Warnings and Precautions for SCHERIPROCT OINTMENT

Scheriproct Ointment contains a corticosteroid. Therefore, adherence to dosage and duration limits is crucial. Consult a physician for guidance, even though it is available without a prescription.

Contraindications and High-Risk Patients

• Hypersensitivity: Do not use if allergic to prednisolone caproate, cinchocaine hydrochloride, other local anesthetics, or any other ointment ingredients.
• Infections: Avoid use if a viral infection (e.g., herpes, shingles, chicken-pox), tuberculosis, or syphilis is present in the treated area. Untreated bacterial or fungal infections also contraindicate use. Any infection must be treated simultaneously with an appropriate anti-infective.
• Pregnancy: Contraindicated during the first trimester of pregnancy due to potential risks to fetal development. Use in later trimesters only if a physician advises and the benefit outweighs the risk, under strict medical supervision.
• Breastfeeding: Use with caution and only if a doctor advises, as small amounts of corticosteroids may pass into breast milk.
• Children: Avoid long-term continuous therapy with topical corticosteroids in infants and small children due to the risk of adrenal suppression.
• Latex Products: Ingredients in Scheriproct ointment (e.g., castor oil) may reduce the effectiveness of latex products like condoms. If applied in the same area, this could compromise contraception or protection against STIs. Consider alternative forms of contraception if this is a concern.

Administration and Monitoring Guidelines

• For External/Rectal Use ONLY: Do not ingest this product.
• Hygiene: Thoroughly wash and dry the anal area before application, ideally after a bowel movement.
• Avoid Waterproof Dressings: Do not cover the treated area with waterproof dressings or tight clothing, as this can increase the systemic absorption of the corticosteroid and skin thinning.
• Eye Contact: Avoid contact with eyes. If contact occurs, rinse thoroughly with water.
• Duration of Use (Crucial): Use for a maximum of 7 days. Prolonged continuous use significantly increases the risk of side effects like skin thinning, systemic absorption, and rebound symptoms upon discontinuation.
• Worsening or Persistent Symptoms: If symptoms worsen, or do not improve after 7 days of treatment, discontinue use and consult a doctor. Persistent symptoms or bleeding require prompt medical evaluation to rule out more serious underlying conditions.
• New Symptoms: Report any new or unusual symptoms to your doctor.

Drug Interactions

• Ritonavir, Cobicistat (HIV Medications): Co-treatment with these medications can increase the risk of systemic corticosteroid side effects. Close monitoring by a doctor is advised.
• Other Topical Steroids: Avoid using other topical corticosteroid products in the same area without medical advice.

Recommended Dosage and Administration Guidelines

Always follow the instructions on the product label or your physician’s guidance for SCHERIPROCT OINTMENT.

• For External Application (around the anus):
  1. Gently but thoroughly wash and dry the anal area.
  2. Squeeze a small quantity (about the size of a pea) of ointment onto your fingertip.
  3. Spread it gently over the skin around the anus and just inside the anal opening. Do not rub it in vigorously.
• For Internal Application (inside the anus):
  1. Screw the provided applicator (nozzle) completely onto the tube.
  2. Squeeze the tube until the applicator fills with ointment (this typically represents one dose).
  3. Carefully insert the applicator entirely into the anus.
  4. While gently squeezing the tube, slowly withdraw the applicator.
• Frequency: Generally, apply the ointment twice daily. For quicker initial relief in severe discomfort, you may apply Scheriproct ointment three to four times on the first day, then reduce to twice daily.
• Duration of Treatment: Use only for a short-term period, usually 5 to 7 days. Do not use for more than 7 days without consulting a doctor due to the risk of side effects from the corticosteroid.
• After Each Use: After each internal application, clean the applicator thoroughly with a paper towel to remove residue. Then, rinse it under warm running water for about 1 minute, and dry it completely with a paper towel before storing.

Price in Kenya (Approximate)

As of Friday, July 4, 2025, at 10:56:50 AM EAT, the approximate price for SCHERIPROCT OINTMENT 30GM (PREDNISOLONE + CINCHOCAINE) in Kenya can range from Ksh 1,500 to Ksh 2,500.

Note: Prices for medications like Scheriproct Ointment can vary between different pharmacies and online retailers in Nairobi, Kiambu County, Kenya. Factors include supplier, specific retail pricing strategies, and any applicable taxes. Always check with specific vendors for the most current pricing.

Conclusion

SCHERIPROCT OINTMENT 30GM, containing Prednisolone Caproate and Cinchocaine Hydrochloride, provides effective short-term relief for the pain, itching, and discomfort associated with haemorrhoids (piles) and anal itching in Kenya. Its dual-action formula rapidly reduces inflammation and provides local numbing. While versatile for both external and internal application, strict adherence to the recommended maximum 7-day usage period is paramount to avoid adverse effects like skin thinning. Though often available without a prescription, usage MUST align with a physician’s guidance to ensure safe and appropriate treatment. If symptoms persist beyond this period, seeking further medical advice is essential to rule out more serious underlying conditions.